Shokhista Bakieva

7 ta ish

Toshkent Kimyo-Texnologiya Instituti

1. Viral hepatitis elimination challenges in low‐ and middle‐income countries—Uzbekistan Hepatitis Elimination Program (UHEP)

   Erkin Musabaev, Chris Estes, Shakhlo Sadirova +10

   MaqolaOAOchiq kirishHepatitis B Virus StudiesLiver International202310 iqtibos

   ABIABI:AkademIndex/2026.other.117944

2. Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model — Tashkent, Uzbekistan, December 6, 2019–March 15, 2020

   Rick Dunn, Erkin Musabaev, Homie Razavi +7

   MaqolaOAOchiq kirish20209 iqtibos

   ABIABI:AkademIndex/2026.other.114019

3. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

   Sarah Blach, Norah A. Terrault, Frank Tacke +97

   Sharh maqolaOAOchiq kirish20224 iqtibos

   ABIABI:AkademIndex/2026.other.117938

4. Barriers and facilitators to viral hepatitis testing in Uzbekistan: scoping qualitative study among key stakeholders, healthcare workers, and the general population

   Alyona Mazhnaya, Brogan Geurts, Krestina Brigida +8

   Maqola20243 iqtibos

   ABIABI:AkademIndex/2026.other.477892

5. Advancing the global public health agenda for NAFLD: a consensus statement

   Jeffrey V. Lazarus, Henry E. Mark, Quentin M. Anstee +97

   Sharh maqolaOAOchiq kirishLiver Disease Diagnosis and TreatmentNature Reviews Gastroenterology & Hepatology20211 iqtibos

   ABIABI:AkademIndex/2021.review-article.000002

6. Molecular characterization of hepatitis B virus genotypes in Uzbekistan

   M. A. Abdukadirova, Aziza Khikmatullaeva, Nargiz Ibadullaeva +1

   MaqolaOAOchiq kirishHepatitis B Virus StudiesInternational Journal of Infectious Diseases20200 iqtibos

   ABIABI:AkademIndex/2020.article.001963

7. The case for testing and treating all HBV patients

   Homie Razavi, Shakhlo Sadirova, Shokhista Bakieva +3

   Maqola20200 iqtibos

   ABIABI:AkademIndex/2020.article.007591